(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DESIGNED FOR THE PATIENT, OPTIMIZED FORTHE LAB

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

DESIGNED FOR THE PATIENT, OPTIMIZED FORTHE LAB

ST13

US500000087354280

Class

1, 5, 9, 10

Filing

87354280

Registration

5576629

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

09/14/2024

Classification

Registered

Trademark type

Word

Nice classes

1, 5, 9, 10

Filing date

03/01/2017

Registration date

10/02/2018

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/03/2024

Last transaction

09/14/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

07/02/2018

First use in commerce

07/02/2018

Drawing code

4

Owner type

16

Owner location

MANNHEIM, DE

Examiner

FRIEDMAN, LESLEE ANN

Law office

N20

Current location

TMO LAW OFFICE 120

Holders and representatives

Holders

ROCHE DIAGNOSTICS GMBH
GenMark Diagnostics, Inc.

Representatives

Mona Gupta Roche Diagnostics Operations, Inc.

Technical classification

Nice Classes

Class 1Class 5Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Reagentskits and cartridges comprised primarily of reagentsbeadsoligonucleotide probes and primers for scientific and research use in connection with the isolationpurificationamplificationanalysislabeling and detection of nucleic acids

Class 5

Reagentskits and cartridges comprised primarily of reagentsbeadsoligonucleotide probes and primers for medicalclinicalmedical laboratory or medical diagnostic use in connection with the isolationpurificationamplificationanalysislabeling and detection of nucleic acids

Class 9

Laboratory equipmentdevices for bioanalysis incorporating cartridges for sample preparationnucleic acid purificationnucleic acid amplification and electrochemical detectionsoftware for use therewith

Class 10

Medical equipmentdevices for bioanalysis incorporating cartridges for sample preparationnucleic acid purificationnucleic acid amplification and electrochemical detectionsoftware for use therewith sold as a unit

Publications

History of USPTO decisions and trademark events.

40 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/10/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

09/10/2024

EWOR

TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED

09/10/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/10/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/10/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

04/03/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

04/03/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/02/2024

E815

TEAS SECTION 8 & 15 RECEIVED

10/06/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/02/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/04/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/04/2021

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/04/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/04/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/04/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/04/2021

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

09/22/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

10/02/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/30/2018

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/30/2018

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/29/2018

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/29/2018

EX2G

SOU EXTENSION 2 GRANTED

08/29/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/23/2018

IUAF

USE AMENDMENT FILED

08/16/2018

EXT2

SOU EXTENSION 2 FILED

08/16/2018

EEXT

SOU TEAS EXTENSION RECEIVED

08/16/2018

EISU

TEAS STATEMENT OF USE RECEIVED

08/16/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/15/2018

EX1G

SOU EXTENSION 1 GRANTED

02/13/2018

EXT1

SOU EXTENSION 1 FILED

02/13/2018

EEXT

SOU TEAS EXTENSION RECEIVED

02/13/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/29/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/04/2017

PUBO

PUBLISHED FOR OPPOSITION

07/04/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/14/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/24/2017

DOCK

ASSIGNED TO EXAMINER

05/24/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/08/2017

NWAP

NEW APPLICATION ENTERED

03/04/2017

Continuous trademark protection

Get notified about every new filing that threatens DESIGNED FOR THE PATIENT, OPTIMIZED FORTHE LAB or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.